scispace - formally typeset
S

Scott E. Klewer

Researcher at University of Arizona

Publications -  75
Citations -  2871

Scott E. Klewer is an academic researcher from University of Arizona. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 19, co-authored 60 publications receiving 2642 citations.

Papers
More filters
Journal ArticleDOI

Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme

TL;DR: The results demonstrate the importance of HA in mammalian embryogenesis and the pivotal role of Has2 during mammalian development and reveal a previously unrecognized pathway for cell migration and invasion that is HA-dependent and involves Ras activation.
Book ChapterDOI

Cell biology of cardiac cushion development.

TL;DR: Cardiac morphogenesis as it relates to heart valve formation is reviewed and selected growth factors, intracellular signaling mediators, and extracellular matrix components involved in the creation and remodeling of endocardial cushions into mature cardiac structures are highlighted.
Journal ArticleDOI

Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors

TL;DR: It is shown that hyaluronan-deficient AVC explants from Has2−/− embryos, which normally lack mesenchyme formation, are rescued by heregulin treatment, which restores phosphorylation of ErbB2 and ErBB3.
Journal ArticleDOI

Temporal and distinct TGFβ ligand requirements during mouse and avian endocardial cushion morphogenesis

TL;DR: Both TGF beta2 and TGFbeta3 appear necessary for the full morphogenetic program of EMT in the chick, but only TGFBeta2 is expressed and obligatory for mammalian endocardial cushion cell transformation.
Journal ArticleDOI

Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer

TL;DR: Compared with values in control subjects, end-systolic left ventricular posterior wall dimension and percent of left vent cardiac posterior wall thickening in doxorubicin-treated patients were decreased at baseline study and these findings were more clearly delineated with dobutamine stimulation.